Skip to main content
. 2020 Sep 2;43(11):2812–2820. doi: 10.2337/dc20-1002

Table 1.

Baseline characteristics of study participants

Baseline characteristic Low-fat diet (n = 85) Mediterranean diet (n = 76) Low-carbohydrate diet (n = 74)
Intervention goal ≤1,500 kcal/day for women and 1,800 kcal/day for men (≤30% calories from fat) ≤1,500 kcal/day for women and 1,800 kcal/day for men (≤35% calories from fat) No calorie restrictions (carbohydrate intake 20 g [induction] to ≤120 g [maintenance] daily)
Age (years) 50.8 ± 6.4 52.7 ± 6.3 51.2 ± 6.2
Male sex 73 (85.7) 66 (86.8) 67 (90.5)
SU, μmol/L (mg/dL) 369 ± 77 (6.2 ± 1.3) 357 ± 89 (6.0 ± 1.5) 357 ± 89 (6.0 ± 1.5)
SU ≥416 μmol/L (≥7 mg/dL) 22 (25.9) 17 (22.4) 18 (24.3)
BMI (kg/m2) 30.5 ± 3.1 30.1 ± 3.2 30.8 ± 3.5
Weight (kg) 90.7 ± 12.2 87.6 ± 12.1 91.5 ± 14.6
Diabetes 11 (12.9) 11 (14.5) 12 (16.2)
Coronary heart disease 28 (32.9) 36 (47.4) 21 (28.4)
Blood pressure (mmHg)
 Systolic 129.8 ± 12.5 131.3 ± 16.3 129.4 ± 14.2
 Diastolic 79.0 ± 8.8 80.0 ± 10.2 77.7 ± 8.1
Lipid profile
 HDL (mmol/L) 0.99 ± 0.25 1.04 ± 0.25 0.97 ± 0.23
 LDL (mmol/L) 2.98 ± 0.89 3.18 ± 0.89 3.13 ± 0.84
 Triglycerides (mmol/L) 1.77 ± 0.71 1.89 ± 0.74 1.94 ± 0.95
 Total cholesterol:HDL-C ratio 5.2 ± 1.4 5.2 ± 1.4 5.6 ± 1.5
eGFR (mL/min/1.73 m2) 96.4 ± 23.4 92.5 ± 18.6 99.4 ± 21.8
Fasting plasma glucose (mmol/L) 4.8 ± 1.1 5.3 ± 2.3 5.0 ± 1.2
Fasting plasma glucose 5.6–6.9 mmol/L* 3 (4.1) 9 (13.8) 5 (8.1)
Fasting plasma insulin (pmol/L) 90.4 ± 50.0 96.6 ± 50.7 100.8 ± 77.1
HOMA-IR 2.8 ± 1.9 3.4 ± 2.7 3.3 ± 3.2
HOMA-IR >3.0* 26 (35.1) 28 (43.1) 25 (40.3)
Statins 21 (24.7) 20 (26.3) 11 (15.0)
Antihypertensive therapy** 19 (22.4) 27 (35.5) 26 (35.2)
Diuretics 5 (5.9) 10 (13.2) 3 (4.0)

Data are mean ± SD or n (%) unless otherwise indicated. HOMA-IR, HOMA of insulin resistance.

*

Among participants without diabetes.

**

Including diuretics.